It is notable that the role of PKN2 in tumor immunomodulation may be associated with the activation of additional immune cell types and inflammatory vesicles, as well as with cellular and molecular mechanisms that play a pivotal role in the tumor microenvironment (Huang et al. 2023). This evidence concerns the gene PKN2 and neoplasm.